会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • PEPTIDE AND PEPTIDE MIMETIC DERIVATIVES WITH INTEGRIN INHIBITOR PROPERTIES II
    • 肽和拟肽衍生物与整合酶抑制剂特点II
    • WO0214350A3
    • 2002-09-19
    • PCT/EP0108931
    • 2001-08-02
    • MERCK PATENT GMBHMEYER JOERGNIES BERTHOLDDARD MICHELHOELZEMANN GUENTERKESSLER HORSTKANTLEHNER MARTINHERSEL ULRICHGIBSON CHRISTOPHSULYOK GABOR
    • MEYER JOERGNIES BERTHOLDDARD MICHELHOELZEMANN GUENTERKESSLER HORSTKANTLEHNER MARTINHERSEL ULRICHGIBSON CHRISTOPHSULYOK GABOR
    • A61L27/00A61K38/00A61P41/00C07K7/06C07K7/08C07K14/78A61K31/195A61K38/39A61L33/00C07C279/18
    • C07K7/06A61K38/00C07K14/78Y02P20/125
    • The invention relates to compounds of formula (I) B-Q-X1, wherein B is a bioactive, cell adhesive mediating molecule, selected from the group (i) and Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (ii), Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (iii), Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg-Lys (iv), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn-Arg (v), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg-Asn (vi), Thr-Trp-Tyr-Lys-Ile-Ala-Phe-Gln-Arg (vii), wherein (i) X, Y, Z, R , R , R , A, Ar, Hal, Het, Het , n, m, o, p, q, s, t have the meanings cited in Claim 1, Q is absent or is an organic spacer molecule, X1 is an anchor molecule selected from the group cited in Claim 1, and the salts thereof, which can be used as integrin inhibitors particularly for treatment of illnesses, deficiencies and inflammations caused by implants and osteolytic illnesses such as osteoporosis, thrombosis, cardiac infarction and arteriosclerosis, in addition to the acceleration and strengthening of the integration process of implants or the biocompatible surface in tissue.
    • 式(I)的化合物:BQ-X1,其中B是生物活性,zelladhäsionsvermittelndes分子从组(i)和Thr-TRP-酪氨酸 - 赖氨酸 - 异亮氨酸 - 丙氨酸 - 苯丙氨酸 - 谷氨酰胺 - 精氨酸 - 天冬酰胺 - 精氨酸 - 赖氨酸选择 (ii)中,TRP-酪氨酸 - 赖氨酸 - 异亮氨酸 - 丙氨酸 - 苯丙氨酸 - 谷氨酰胺 - 精氨酸 - 天冬酰胺 - 精氨酸 - 赖氨酸(iii)中,酪氨酸 - 赖氨酸 - 异亮氨酸 - 丙氨酸 - 苯丙氨酸 - 谷氨酰胺 - 精氨酸 - 天冬酰胺 - 精氨酸 - 赖氨酸(ⅳ ),苏氨酸-TRP-酪氨酸 - 赖氨酸 - 异亮氨酸 - 丙氨酸 - 苯丙氨酸 - 谷氨酰胺 - 精氨酸 - 天冬酰胺 - 精氨酸(v),苏氨酸-TRP-酪氨酸 - 赖氨酸 - 异亮氨酸 - 丙氨酸 - 苯丙氨酸 - 谷氨酰胺 - 精氨酸 - 天冬酰胺(VI), THR-TRP-酪氨酸 - 赖氨酸 - 异亮氨酸 - 丙氨酸 - 苯丙氨酸 - 谷氨酰胺 - 精氨酸(VII),其中对于(I)中X,Y,Z,R <2>,R <3>,R <4>中,A中,Ar 中,Hal中,Het中,Het <1>中,n,M,O,p,Q,S,T具有权利要求1中所示的含义,Q不存在或者为有机间隔分子,X 1是锚定分子,权利要求在从所选择的 图1是指定的组,以及它们的盐可以用作整联蛋白抑制剂,特别是用于引起植入物,缺陷,炎症和溶骨性疾病如骨质疏松症,血栓形成,心脏梗塞和动脉粥样硬化的疾病的治疗,并且还为INTEGRA的加速和强化 植入物或生物相容的表面的onsprozesses在所述组织中。
    • 5. 发明申请
    • IMPLANT MATERIAL BASED ON A POLYMER SYSTEM AND THE USE THEREOF
    • 植入材料基于聚合物系统及其用途
    • WO2008116905A3
    • 2009-09-17
    • PCT/EP2008053640
    • 2008-03-27
    • INNOTERE GMBHNIES BERTHOLD
    • NIES BERTHOLD
    • A61L24/00A61L24/04A61L27/14A61L27/44
    • A61L24/0042A61L24/0036A61L24/0073A61L27/44A61L27/56A61L27/58
    • The invention relates to an implant material based on a polymer system composed of at least two components and the use thereof as a bone cement, bone replacement material, or active ingredient carrier. The implant material according to the invention is based on a polymer system and composed of at least two components that react with one another upon mixing and form a polymer-based solid, wherein the first component of the polymer system is a paste comprising at least one biocompatible polymer powder and a starter component for the initiation of a polymerization reaction upon mixing, wherein the paste is formed with the aid of a carrier liquid, wherein, under normal conditions, the polymer powder does not dissolve or significantly swell in the carrier liquid and the starter component remains stable until being mixed with the second component of the polymer system, and wherein the second component of the polymer system comprises at least one reactive organic liquid or a solution or a suspension of a reactive organic liquid and a polymer.
    • 本发明涉及基于包含至少2种组分的聚合物系统上的植入材料,其作为骨水泥,骨替换材料或赋形剂的用途。 根据本发明的聚合物体系的基础上,所述植入物材料由其中当混合在一起以形成反应至少2成分的聚合物为基础的固体,其中所述聚合物系统的第一组分是含有至少一种生物相容的聚合物粉末的糊剂,并用于在混合引发聚合反应的引发剂组分 包括,其中所述糊状物是通过载液,其中在所述载体液中,所述聚合物粉末不正常条件下溶解或显著溶胀的装置形成,并且所述引发剂组分到混合物中保持稳定的聚合物体系的第二组分,并且其中所述聚合物体系的第二组分的至少一种反应性 含有有机液体或溶液或悬浮液的反应性有机液体和聚合物。
    • 7. 发明申请
    • BIOACTIVE BONE CEMENT AND METHOD FOR THE PRODUCTION THEREOF
    • 生物活性骨水泥及其制造方法
    • WO2006122678A2
    • 2006-11-23
    • PCT/EP2006004330
    • 2006-05-09
    • NIES BERTHOLD
    • NIES BERTHOLD
    • A61L24/06
    • A61L24/06A61L24/001A61L27/16A61L27/50A61L2430/02C08L33/08
    • The invention relates to a novel bioactive and osteoconductive bone cement and a method for producing the same from polyacrylates or polymethylacrylates by adding small amounts of polymerizable monomers containing anionic groups which cause the cement surface to mineralize after being incubated in simulated body fluid and in which the obtained mineralized layers contain calcium phosphate phases such that the formation of fibrous intermediate layers is prevented once the bone cement has been implanted in bones. Optionally, other additives, e.g. biocompatible calcium salts, and/or biocompatible buffer substances, or x-ray contrasting agents, antibiotics, antimicrobial agents, and/or anti-inflammatory agents can be added in order to improve the properties of the cement for individual purposes. The invention also relates to the use of the disclosed bone cement for anchoring prosthesis components in the bone, stiffening bones, filling and reconstructing all types of bone defects, as dowels for bone screws, or as an implant material for anchoring screws and other implants used for osteosynthesis.
    • 本发明描述了一种新的骨粘固剂,其是生物活性和骨传导性,以及用于其生产的聚丙烯酸酯或聚与添加少量含有可导致水泥表面的矿化在模拟体液中温育后的阴离子基团的聚合性单体中的方法,并在其中 矿化所得的各层包含在它们的组成磷酸钙相,从而使植入到骨后,纤维中间层的形成被抑制。 , 此外,任选的进一步的添加剂,例如。 B.生物相容的钙盐,和/或生物相容的缓冲液中添加,或甚至X射线造影剂,抗生素; 为了抗微生物剂和/或抗炎剂,以改善水泥个别用途的性质。 本发明进一步提供根据本发明的用于在骨锚固假体部件,用于加强骨,用于填充和任何种类的骨缺损的修复中使用的骨水泥,作为锚用于骨螺钉或作为用于锚定螺钉包括植入材料 植入物接骨。
    • 9. 发明申请
    • HYDRAULIC CEMENT-BASED IMPLANT MATERIAL AND USE THEREOF
    • 植入材料,以一个硬性水泥,及其用途
    • WO2008148878A3
    • 2009-11-26
    • PCT/EP2008057099
    • 2008-06-06
    • INNOTERE GMBHNIES BERTHOLD
    • NIES BERTHOLD
    • A61K6/02A61K6/06A61L24/02
    • A61L24/0084A61K6/0008A61K6/0023A61K6/0067A61K6/0643A61K6/0675A61L24/02A61L27/40A61L2430/02C08L71/02C08L33/08
    • The invention relates to implant materials that are based on hydraulic cements in the form of one or more pastes, suspensions or dispersions that contain mineral and/or organic and/or organomineral solids and that react, when combined or when reacted with an aqueous liquid, to a solid in a cement-type initiation reaction. The invention also relates to the use of these materials as technical, medical-technical and/or pharmaceutical products, especially as bone cements, bone replacement materials, bone glues, dental filling materials and implantable active ingredient carriers. The implant materials according to the invention in the form of one or more pastes, suspensions or dispersions that contain mineral and/or organic and/or organomineral solids are formulated in an excipient liquid in such a manner that the pastes, suspensions or dispersions are stable in storage at normal conditions over a prolonged period of time and that they react, when combined with an aqueous liquid or when added to an aqueous liquid, in a cement-type initiation reaction and set to a solid. The excipient liquid of the mineral paste, suspension or dispersion is substantially water-free, and water immiscible or insoluble or hardly soluble in water in the chemical sense.
    • 本发明涉及基于在一种或多种矿物的形式的水硬性水泥植入物材料和/或有机的和/或有机矿物糊剂,悬浮液或分散体,其组合或反应中反应以在水泥凝固反应的固体的含水液体以及含固体的其 使用作为工业,医疗和/或药物产品,特别是作为骨接合剂,骨替换材料,骨粘合剂,​​牙齿的填充材料和可植入的药物递送。 根据本发明中一种或多种矿物的形式的植入物材料和/或有机的和/或有机矿物糊,悬浮液中或在载体液体配制的分散体含固体的,该糊剂,悬浮液或分散体是储存在正常条件下长时间稳定,并且它们在组合 与水性液体或通过引入反应成水性液体在水泥凝固反应并凝固成固体。 这里,矿物浆,悬浮液或分散体,基本上无水的,并且在化学意义上的载体液是不与水混溶或不或仅微溶于水。